PTD-XIAP protects against cerebral ischemia by anti-apoptotic and transcriptional regulatory mechanisms
2006 | journal article; research paper. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
PTD-XIAP protects against cerebral ischemia by anti-apoptotic and transcriptional regulatory mechanisms
Guegan, C.; Braudeau, J.; Couriaud, C.; Dietz, G. P. H. ; Lacombe, P.; Bähr, M. & Nosten-Bertrand, M. et al. (2006)
Neurobiology of Disease, 22(1) pp. 177-186. DOI: https://doi.org/10.1016/j.nbd.2005.10.014
Documents & Media
Details
- Authors
- Guegan, C.; Braudeau, J.; Couriaud, C.; Dietz, Gunnar P. H. ; Lacombe, P.; Bähr, M. ; Nosten-Bertrand, M.; Onteniente, B.
- Abstract
- Caspases play a major role in the infarction process that follows occlusion of cerebral arteries and are important targets for stroke therapy. We have generated three fusion proteins that link various domains of the X chromosome-linked inhibitor of apoptosis (XIAP), a potent caspase inhibitor, to the protein transduction domain (PTD) of HIV-1/Tat, and have tested their efficacy after distal occlusion of the middle cerebral artery (dMCAO) in mice. PTD-XIAP failed to accumulate in brain structures after intravenous (iv) delivery, but properly transduced cortical cells when applied topically. Shorter constructs efficiently targeted the lesion after iv delivery. All proteins retained their caspase inhibitory activity and significantly reduced infarct volumes. PTD-XIAP reversed long-term impairments in the water maze test. Sequential activation of transcription factors was observed, suggesting that the effects of XIAP are mediated by both direct inhibition of apoptotic mechanisms and secondary regulation of transcription factors involved in neuronal survival. (c) 2005 Elsevier Inc. All rights reserved.
- Issue Date
- 2006
- Journal
- Neurobiology of Disease
- ISSN
- 0969-9961
- Language
- English